Disclosure of Conflicts of Interest

CE Reporting: You will receive an email with instructions on accessing the portal following the conclusion of the Virtual Experience. 

2021 Fall IDN Summit

This activity is jointly provided by

Faculty/Planner/Reviewer Disclosure of Conflicts of Interest

Disclosure of Conflicts of Interest

AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is t producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity. 

 

AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.

 

The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

 

Name of Faculty or Presenter

Reported Financial Relationship

Chris Box

Nothing to disclose

Martina Brooks

Nothing to disclose

Mark Campbell

Nothing to disclose

Jimmy Y. Chung, MD, MBA, FACS, FABQAURP, CMRP

Nothing to disclose

Arash T. Dabestani PharmD, MHA, FASHP, FABC

Consultant: Omnicell

Marisa Farabaugh

Nothing to disclose

Nick Gaich

Nothing to disclose

Abel Haile

Nothing to disclose

Tom Harvieux

Nothing to disclose

Bonnie Kirschenbaum, BScPharm, MS, FASHP, FCSHP

Nothing to disclose

Gina Lohr

Nothing to disclose

Deepak Manmohan Goyal MD, MBBS, CPE, CHCQM-PHYADV

Nothing to disclose

Steven Schnelle

Nothing to disclose

Joanne Schlosser

Nothing to disclose

Rodney Whitlock, PhD

Nothing to disclose

Kenny Yu, Pharm.D., MBA, ACE

Nothing to disclose

 

The planners/managers/reviewers reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

 

Name of Planner/Manager

Reported Financial Relationship

Brent Petty, CMRP

Nothing to disclose

Ellie Wnek

Nothing to disclose

Robert Chafin

Nothing to disclose

Dee Morgillo, MEd., MT(ASCP), CHCP

Nothing to disclose

Holly M. Hampe, D.Sc., RN, MHA, MRM

Nothing to disclose